Inventor · disambiguated record
James A. Bianco
Also filed as: BIANCO JAMES · BIANCO JAMES A
15 granted patents·4 pending applications·316 citations·filing 1994–2022
95Inventor score
Files withCELL THERAPEUTICS INC14HUTCHINSON FRED CANCER RES3H LEE MOFFITT CANCER CT & RES1WEST VIRGINIA UNIV BOARD OF GOVERNORS ON BEHALF OF WEST VIRGINIA UNIV1
Top patents by PatentIndex Score
19 records- 0189US5648357AEnatiomerically pure hydroxylated xanthine compoundsCELL THERAPEUTICS INC·Filed 1994·Granted Jul 15, 1997·59 cites·10 claims
- 0280US5585380AModulation of cellular response to external stimuliHUTCHINSON FRED CANCER RES·Filed 1995·Granted Dec 17, 1996·50 cites·6 claims
- 0376US5652243AMethods of using enantiomerically pure hydroxylated xanthine compoundsCELL THERAPEUTICS INC·Filed 1994·Granted Jul 29, 1997·18 cites·4 claims
- 0475US5621102AProcess for preparing enantiomerically pure xanthine derivativesCELL THERAPEUTICS INC·Filed 1995·Granted Apr 15, 1997·22 cites·10 claims
- 0575US5620984AEnatiomerically pure hydroxylated xanthine compounds to treat inflammatory diseasesCELL THERAPEUTICS INC·Filed 1995·Granted Apr 15, 1997·21 cites·3 claims
- 0675US5580873AEnatiomerically pure hydroxylated xanthine compounds to treat proliferative vascular diseasesCELL THERAPEUTICS INC·Filed 1995·Granted Dec 3, 1996·23 cites·3 claims
- 0773US5965564AEnantiomerically pure hydroxylated xanthine compoundsCELL THERAPEUTICS INC·Filed 1998·Granted Oct 12, 1999·19 cites·12 claims
- 0873US5739138AEnantiomerically pure hydroxylated xanthine compounds to treat autoimmune diabetesCELL THERAPEUTICS INC·Filed 1995·Granted Apr 14, 1998·19 cites·2 claims
- 0973US5629315ATreatment of diseases using enantiomerically pure hydroxylated xanthine compoundsCELL THERAPEUTICS INC·Filed 1995·Granted May 13, 1997·19 cites·5 claims
- 1072US5792772AEnatiomerically pure hydroxylated xanthine compoundsCELL THERAPEUTICS INC·Filed 1995·Granted Aug 11, 1998·18 cites·4 claims
- 1168US2008146598A1Combinatorial drug therapy using polymer-drug conjugatesCELL THERAPEUTICS INC·Filed 2008·Application pending·0 cites
- 1264US2024189441A1A delta-opioid receptor targeted agent for molecular imaging and immunotherapy of cancerWEST VIRGINIA UNIV BOARD OF GOVERNORS ON BEHALF OF WEST VIRGINIA UNIV·Filed 2022·Application pending·0 cites
- 1363US5567704AR-enatiomerically pure hydroxylated xanthine compounds to treat baldnessCELL THERAPEUTICS INC·Filed 1995·Granted Oct 22, 1996·7 cites·4 claims
- 1462US6420374B1Use of xanthines as immunosuppressants and to inhibit allograft reactionsHUTCHINSON FRED CANCER RES·Filed 1996·Granted Jul 16, 2002·23 cites·19 claims
- 1559US2004047835A1Combinatorial drug therapy using polymer drug conjugatesCELL THERAPEUTICS INC·Filed 2003·Application pending·0 cites
- 1657US5580874AEnatiomerically pure hydroxylated xanthine compoundsCELL THERAPEUTICS INC·Filed 1995·Granted Dec 3, 1996·14 cites·4 claims
- 1751US2023158016A1Delta opioid receptor antagonists reprogram immunosuppressive microenvironment to boost immunotherapyH LEE MOFFITT CANCER CT & RES·Filed 2021·Application pending·0 cites
- 1849US5612349AEnantiomerically pure hydroxylated xanthine compounds to treat shock symptomsCELL THERAPEUTICS INC·Filed 1995·Granted Mar 18, 1997·4 cites·4 claims
- 1930US5856115AAssay for identification therapeutic agentsHUTCHINSON FRED CANCER RES·Filed 1994·Granted Jan 5, 1999·0 cites·4 claims
Join the waitlist — get patent alerts
Get an alert when James A. Bianco files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →